-+ 0.00%
-+ 0.00%
-+ 0.00%

GENERATE BIOMEDICINES INC : MORGAN STANLEY INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $20

Reuters·03/25/2026 11:01:18

Please log in to view news